We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Employment Tribunal decision.
Clare Fitzsimmons has been appointed to the Board of Natural England, with Lord Blencathra, Catherine Dugmore and Henry Robinson reappointed.
First published during the 2019 to 2022 Johnson Conservative government
The CMA investigated the anticipated acquisition by Clariant of the European aircraft de-icing fluid and rail de-icing fluid business of the Kilfrost Group.
A new national campaign is calling on those eligible not to ignore their invite, as data reveals nearly 1 in 3 don’t take up the offer of cervical screening.
While an urgent EU-wide review of new information on liver safety is under way, promptly review patients on treatment. Only initiate daclizumab in restricted groups of patients with limited treatment options and keep all patients under close liver function monitoring.
(Mylan on behalf of Strides Arcolab International Limited) Remaining stocks of affected batches should be quarantined - class 2 action within 48 hours. (EL (14)A/07)
OFT closed case: Completed acquisition by Acxiom Corporation of Clarita Europe Group, including Claritas (UK) Ltd.
Clariant’s anticipated acquisition of Kilfrost’s de-/anti-icing fluids business could be blocked by the CMA.
Clariant’s anticipated acquisition of Kilfrost’s de-/anti-icing fluids business faces being referred for an in-depth investigation by the CMA.
Claris Lifesciences UK Ltd are asking pharmacists and wholesalers to check packs of Furosemide-Claris 20mg/2ml Injection (Marketing Authorisation number AUST R 148003) as they have been inadvertently distributed in the UK and are intended for the Australian market.
A pharmaceutical company supported by Innovate UK is leading the world in the search for vital new antibiotics to treat resistant bacteria.
Letters were sent to healthcare professionals about Zinbryta▼ (daclizumab beta), Lynparza 50 mg capsules, and radium-223-dichloride (Xofigo▼).
The use of daclizumab (daclizumab beta) is now restricted to adults with relapsing multiple sclerosis who have had an inadequate response to at least 2 other disease-modifying therapies (DMTs) and for whom other DMTs are contraindicated or unsuitable. Do not...
The CMA investigated the anticipated acquisition by Experian Limited of Credit Laser Holdings Limited (ClearScore)
Claridon Group becomes the first privately owned British company to establish an office in Burma.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).